Presenting features of breast cancer differ by molecular subtype

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Gene expression profiling reveals distinct breast cancer subtypes impacting prognosis.
• Understanding subtype-specific tumor presentation is crucial for effective treatment.

Purpose of the Study:

• To investigate differences in presenting features among breast cancer molecular subtypes.
• To correlate clinicopathologic variables with molecular subtypes.

Main Methods:

• Classified 6,072 invasive breast tumors into luminal A, luminal B, HER-2, and basal subtypes using immunohistochemical surrogates.
• Utilized chi-squared test, ANOVA, and multivariate logistic regression to analyze associations between subtypes and clinicopathologic variables.

Main Results:

• Significant differences in age, tumor size, lymph node involvement, nuclear grade, multicentricity, lymphovascular invasion (LVI), and intraductal component were observed across subtypes.
• HER-2-overexpressing tumors (luminal B, HER-2) showed increased nodal involvement, multifocal disease, extensive intraductal component, and LVI compared to luminal A.
• Multivariate analysis confirmed HER-2 subtype tumors were more likely to have extensive lymph node metastasis and multifocal disease.

Conclusions:

• Breast cancer tumor presentation varies significantly among molecular subtypes.
• Identifying these differences can aid in selecting appropriate local therapies.
• Neoadjuvant therapy and pre-surgical lymph node evaluation are recommended for HER-2-overexpressing tumors.